1 Lilly also reduced the price of the 2.5 mg and 5 mg vials. These new offerings are ... receiving two years of continuous treatment with Omvoh® (mirikizumab-mrkz) achieved long-term clinical ...

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's disease, extending its use beyond ulcerative colitis (UC) for the first time.

Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...

In February, Lilly cut prices for patients paying for single-dose Zepbound vials without insurance by $50 a month for 2.5 milligrams, a common starting dosage, and 5 milligrams. The charge is $349 ...

Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

vial Novolog Mix 70/30 vial (Novo Nordisk) 28 days Prescribing information Lente human insulin (rDNA origin) zinc suspension Humulin L (Lilly) 28 days Prescribing information Insulin lispro (rDNA ...

Sophie Turner, Kate Moss, Nara Smith - the most stylish A-list attendees spotted in the 'City of Light' for the autumn-winter shows ...